A strategy to advance the evidence base in palliative medicine: Formation of a palliative care research cooperative group

Journal of Palliative Medicine

Volumn 13, Issue 12, 2010, Pages 1407-1413

  Abernethy, Amy P ^a,b   Aziz, Noreen M ^c   Basch, Ethan ^d   Bull, Janet ^e   Cleeland, Charles S ^f   Currow, David C ^g,h   Fairclough, Diane ⁱ   Hanson, Laura ^j   Hauser, Joshua ^k   Ko, Danielle ^l   Lloyd, Linda ^m   Morrison, R Sean ⁿ   Otis Green, Shirley ^o   Pantilat, Steve ^p   Portenoy, Russell K ^q   Ritchie, Christine ^r   Rocker, Graeme ^s   Wheeler, Jane L ^a   Zafar, S Yousuf ^a   Kutner, Jean S ^t  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e University of Texas ^*  (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g FLINDERS UNIVERSITY   (Australia)

^h REPATRIATION GENERAL HOSPITAL   (Australia)

ⁱ Global Health and Health Disparities   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

^m Institute for Palliative Medicine   (United States)

ⁿ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^o CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q BETH ISRAEL MEDICAL CENTER   (United States)

^r UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^s DALHOUSIE UNIVERSITY   (Canada)

^t UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

STATIN;

ARTICLE; CLINICAL PRACTICE; CONSENSUS; DECISION MAKING; EVIDENCE BASED MEDICINE; GOVERNMENT; HUMAN; INDUSTRY; INFORMATION PROCESSING; MEDICAL EDUCATION; METHODOLOGY; PALLIATIVE THERAPY; POLICY; PRIMARY PREVENTION; PROGNOSIS; QUALITY CONTROL; RESEARCH; SECONDARY PREVENTION; STANDARDIZATION;

COOPERATIVE BEHAVIOR; EVIDENCE-BASED MEDICINE; HEALTH SERVICES RESEARCH; HUMANS; PALLIATIVE CARE;

EID: 78649368789     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2010.0261     Document Type: Article

References (43)

1. Tieman J, Sladek R, Currow D: Changes in the quantity and level of evidence of palliative and hospice care literature: The last century. J Clin Oncol 2008;26:5679-5683.
2. www.hospicecare.com/iahpc-press/ (Last accessed November 10, 2010).
3. Gelfman LP, Morrison RS: Research funding for palliative medicine. J Palliat Med 2008;11:36-43.
4. Institute of Medicine: Improving Palliative Care for Cancer. Washington, D.C.: National Academy of Science, National Academies Press, 2001.
5. Foley KM, Gelband HG: Improving Palliative Care for Cancer. Washington, D.C.: National Academy Press, 2001.
6. Paper presented at: National Institutes of Health State-ofthe- Science Conference Statement on Improving End-of-Life Care. Bethesda, MD: 2004.
7. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander- Klar H, Coyle N, Smart-Curley T, Kemeny N, Norton L, Hoskins W, et al: Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 1994;3: 183-189.
8. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330: 592-596.
9. Clark JD: Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002;23:131-137.
10. Cosby AG, Hitt HC, Thornton-Neaves T, McMillen RC, Koch K, Sitzman BT, Pearson EJ, Parvin TS: Profiles of pain in Mississippi: Results from the Southern Pain Prevalence Study. J Miss State Med Assoc 2005;46:301-309.
11. Casarett D, Karlawish J, Hirschman K: Are hospices ready to participate in palliative care research? Results of a nationwide survey. J Palliat Med 2001;5:397-406.
12. Abernethy AP, Hanson LC, Main DS, Kutner JS: Palliative care clinical research networks, a requirement for evidencebased palliative care: Time for coordinated action. J Palliat Med 2007;10:845-850.
13. Rinck GC, van den Bos GA, Kleijnen J, de Haes HJ, Schade E, Veenhof CH: Methodologic issues in effectiveness research on palliative cancer care: A systematic review. J Clin Oncol 1997;15:1697-1707.
14. Curtis JR, Morrison RS: The future of funding for palliative care research: Suggestions for our field. J Palliat Med 2009; 12:26-28.
15. Institute of Medicine: A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, D.C.: Institute of Medicine, National Academy of Sciences, 2010.
16. Harras A, Edwards BK, Blot WJ, Ries LAG: Cancer: Rates and Risks, 4th ed. Bethesda, MD: National Cancer Institute, 1996.
17. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L: SEER Cancer Statistics Review,1975-2000. Bethesda, MD: National Cancer Institute, 2003.
18. Ruccione KS, Hinds PS, Wallace JD, Kelly KP, Children's Oncology Group Nursing D: Creating a novel structure for nursing research in a cooperative clinical trials group: The Children's Oncology Group experience. Semin Oncol Nurs 2005;21:79-88.
19. Ross JA, Severson RK, Pollock BH, Robison LL: Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 1996;77:201-207.
20. Reaman GH: Clinical advances in pediatric hematology & oncology: Cooperative group research. Clin Adv Hematol Oncol 2005;3:133-135.
21. Dilts DM, Sandler AB: Activating & Opening Oncology Clinical Trials: Process & Timing Analysis; July 1-2, 2008. National Cancer Policy Forum. Multi-site Clinical Trials and the NCI Cooperative Group Program: A Workshop: Institute of Medicine.
22. Doroshow JH: Improving the Efficiency of Clinical Trials: Decreasing Activation Times by Fifty Percent. NCI Cancer Bulletin. 2010, Volume 7, Number 7.
23. Dilts DM, Sandler AB, Baker M, Cheng SK, George SL, Karas KS, McGuire S, Menon GS, Reusch J, Sawyer D, Scoggins M, Wu A, Zhou K, Schilsky RL; Case of Cancer and Leukemia Group B: Processes to activate phase III clinical trials in a Cooperative Oncology Group: The Case of Cancer and Leukemia Group B. J Clin Oncol 2006;24:4553-4557.
24. Dilts DM, Sandler A, Cheng S, Crites J, Ferranti L, Wu A, Gray R, MacDonald J, Marinucci D, Comis R: Development of clinical trials in a cooperative group setting: The Eastern Cooperative Oncology Group. Clin Cancer Res 2008;14:3 427-3433.
25. Currow DC, Shelby-James TM, Agar M, Plummer J, Rowett D, Glare P, Spruyt O, Hardy J: Planning phase III multi-site clinical trials in palliative care: The role of consecutive cohort audits to identify potential participant populations Support Care Cancer (in press).
26. www.health.gov.au/palliativecare (Last accessed October 19, 2010).
27. www.ccctg.ca/index.php (Last accessed October 19, 2010).
28. www.ntnu.no/prc. (Last accessed October 19, 2010).
29. Lundstrom S, Gyllenhammar E, Martinsson U, Strang P: Together we can: Experiences from 7 years of cross-sectional studies in a Swedish palliative care clinical research network. Palliat Med 2010;24:261-266.
30. Kutner JS, Main DS, Westfall JM, Pace W: The practice-based research network as a model for end-of-life care research: Challenges and opportunities. Cancer Control 2005;12: 186-195.
31. Stevenson JM, Abernethy AP, Currow DC: Management of long-term comorbidities in the setting of end stage disease. BMJ 2004;329:909-912.
32. LeBlanc TW, Kutner JS, Ko D, Wheeler JL, Bull J, Abernethy AP: Developing the evidence base for palliative care: Formation of the Palliative Care Research Cooperative and its first trial. Hosp Pract (Minneap) 2010;38:137-143.
33. Agency for Healthcare Research and Quality: Trends in Statin Use in the Civilian Noninstitutionalized Medicare Population, 1997 and 2002. September 27, 2005.
34. Amarenco P, Labreuche J, Lavallee P, Touboul PJ: Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis. Stroke 2002;35:2902-2909.
35. Heart Protection Study Collaborative G. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebocontrolled trial. [Summary for patients in Curr Cardiol Rep 2002;4:486-487;
36. PMID: 12379169]. Lancet 2002;360:7-22.
37. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet 2003;361:1149-1158. (Pubitemid 36398384)
38. Newman CB, Palmer G, Silbershatz H, Szarek M: Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. Am J Cardiol 2003;92:670-676.
39. Omar MA, Wilson JP: FDA adverse event reports on statinassociated rhabdomyolysis. Ann Pharmacother 2002;36:288-295.
40. Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, März W, Reckless JP, Stein EA: Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med 2003;163:553-564.
41. Daskalopoulou SS, Delaney JAC, Filion KB, Brophy JM, Mayo ME, Suissa S: Discontinuation of statin therapy following an acute myocardial infarction: A population-based. study. Eur Heart J 2008;29:2083-2091.
42. Vollrath AM, Sinclair C, Hallenbeck J: Discontinuing cardiovascular medications at the end of life: Lipid-lowering agents. J Palliat Med 2005;8:876-881.
43. Abernethy AP, Currow DC, Wurzelmann J, Janning SW, Bull J, Norris JF, Baringtang DC, Pierce A, Snidow J: . Enhancing enrollment in palliative care trials: Key insights from a randomized, placebo-controlled study. J Support Oncol 2010;8:139-144.